Article Details
Retrieved on: 2018-05-03 15:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Two Sigma Investments</b> LP purchased a new stake in NewLink Genetics Co. (NASDAQ:NLNK) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 38,443 shares of the biotechnology company's stock, valued at ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here